Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	71.4	182.48	41.57	187.62	185.42	36.98
Short-Term Investments	141.89	7.97	80.09	106.3	84.2	16.35
Cash & Short-Term Investments	213.29	190.44	121.67	293.92	269.62	53.33
Cash Growth	21.51%	56.53%	-58.61%	9.01%	405.59%	516.72%
Prepaid Expenses	2.49	6.78	19.06	2.45	0.96	0.07
Other Current Assets	15.63	14.67	2.25	0.25	-	-
Total Current Assets	231.41	211.89	142.98	296.62	270.58	53.4
Property, Plant & Equipment	139.92	71.56	36.6	48.55	15.68	0.6
Other Long-Term Assets	13.69	14.06	14.28	15.14	15.6	0.79
Total Assets	385.01	297.51	193.85	360.31	301.86	54.78
Accounts Payable	9.35	11.35	19.54	4.33	1.44	0.25
Accrued Expenses	8.94	11.82	10.23	9.02	36.19	0.74
Short-Term Debt	-	-	-	-	-	17.52
Current Portion of Leases	7.71	3.61	9.28	11.69	7.34	-
Current Unearned Revenue	6.95	7.09	-	-	-	-
Other Current Liabilities	2.06	4.08	17.38	1.67	13.02	0.93
Total Current Liabilities	35.02	37.96	56.42	26.71	57.98	19.44
Long-Term Leases	110.42	37.18	4.36	17.05	3.07	-
Long-Term Unearned Revenue	59.75	63.22	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.28	1.24	1.87
Other Long-Term Liabilities	18	6	-	-	-	-
Total Liabilities	223.19	144.36	60.78	44.04	62.3	21.31
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	1,004	840.36	624.41	609.85	15.16	8.35
Retained Earnings	-842.28	-687.21	-491.33	-293.2	-171.38	-6.01
Comprehensive Income & Other	0.03	0	-0.02	-0.38	-0.03	-
Total Common Equity	161.82	153.15	133.07	316.27	-156.24	2.34
Shareholders' Equity	161.82	153.15	133.07	316.27	239.56	33.47
Total Liabilities & Equity	385.01	297.51	193.85	360.31	301.86	54.78
Total Debt	118.14	40.79	13.63	28.75	10.41	17.52
Net Cash (Debt)	95.15	149.65	108.03	265.18	259.21	35.81
Net Cash Growth	-29.14%	38.52%	-59.26%	2.30%	623.80%	314.17%
Net Cash Per Share	0.69	1.26	1.19	7.82	19.98	13.57
Filing Date Shares Outstanding	177.04	127.66	115.2	88.4	17.06	24.32
Total Common Shares Outstanding	176.84	127.66	92.64	88.36	17.06	24.32
Working Capital	196.39	173.93	86.55	269.9	212.6	33.96
Book Value Per Share	0.92	1.20	1.44	3.58	-9.16	0.10
Tangible Book Value	161.82	153.15	133.07	316.27	-156.24	2.34
Tangible Book Value Per Share	0.92	1.20	1.44	3.58	-9.16	0.10
Machinery	32.67	29.29	24.16	19.67	5.42	0.64
Construction In Progress	0.02	3.58	5.4	1.61	-	-
Leasehold Improvements	7.91	5.14	0.58	0.56	0.13	-

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q